Grant: CIHR Fellowship
Direct Payment
$150,000.00
Regulation of osteoblast differentiation by FosB and Wnt signalling interactions.
EF 2010-11
Résumé
Bone cells are responsible for making strong healthy bones. In patients experiencing osteoporotic disease, the amount of bone made is reduced resulting in a higher incidence of fractures. The number of bone-forming cells and their activity levels are controlled by genes and proteins. A mouse model that makes high levels of DFosB proteins (or its close relative D2DFosB)builds larger bones than normal mice. It is still unclear exactly how DFosB and D2DFosB causes this enhanced bone-building effect. Preliminary evidence suggests that FosB might interact with another bone building protein known as ß-catenin. ß-catenin is a major regulator of bone cell activity. In this project, we propose to use in-vitro and in-vivo experiments to understand the mechanism of FosB and ß-catenin interactions and the role these interactions have on bone formation. Understanding the mechanisms by which DFosB and D2DFosB enhance bone formation might reveal possible drug targets for the therapeutic management of osteoporotic diseases.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
214107
Name
Addison William N
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Regulation of osteoblast differentiation by FosB and Wnt signalling interactions.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bone; Osteoblast; Osteoporosis; Signal Transduction; Transgenics
Abstract
Bone cells are responsible for making strong healthy bones. In patients experiencing osteoporotic disease, the amount of bone made is reduced resulting in a higher incidence of fractures. The number of bone-forming cells and their activity levels are controlled by genes and proteins. A mouse model that makes high levels of DFosB proteins (or its close relative D2DFosB)builds larger bones than normal mice. It is still unclear exactly how DFosB and D2DFosB causes this enhanced bone-building effect. Preliminary evidence suggests that FosB might interact with another bone building protein known as ß-catenin. ß-catenin is a major regulator of bone cell activity. In this project, we propose to use in-vitro and in-vivo experiments to understand the mechanism of FosB and ß-catenin interactions and the role these interactions have on bone formation. Understanding the mechanisms by which DFosB and D2DFosB enhance bone formation might reveal possible drug targets for the therapeutic management of osteoporotic diseases.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Addison, William N
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~